(Q37794273)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Neuromyelitis optica (NMO)--an autoimmune disease of the central nervous system (CNS) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Nasrin Asgari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Trevor Owens

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Egon Stenager

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Søren Thue Lillevang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

J Frøkiaer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

English

0 references

publication date

29 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

Acta Neurologica Scandinavica

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

369-384

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Neuromyelitis optica: changing concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Neuromyelitis optica: a distinct demyelinating disease of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Differential diagnosis of suspected multiple sclerosis: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Neuromyelitis optica with hypothalamic involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Recurrent optic neuromyelitis with endocrinopathies: a new syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Cognitive functions in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Neuromyelitis optica in France: a multicenter study of 125 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Diagnosis and treatment of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Anti-aquaporin-4 antibody-positive optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Multiple sclerosis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

NMO-IgG predicts the outcome of recurrent optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Neuromyelitis optica in a mother and daughter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Aquaporin water channels--from atomic structure to clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Knock-out models reveal new aquaporin functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Brain mitochondria contain aquaporin water channels: evidence for the expression of a short AQP9 isoform in the inner mitochondrial membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Analysis of mice with targeted deletion of AQP9 gene provides conclusive evidence for expression of AQP9 in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Evolving perspectives on clopidogrel in the treatment of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Aquaporin-11 containing a divergent NPA motif has normal water channel activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Water movements in the brain: role of aquaporins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Aquaporins in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Perivascular spaces and the two steps to neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

The human AQP4 gene: definition of the locus encoding two water channel polypeptides in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

cDNA cloning, gene organization, and chromosomal localization of a human mercurial insensitive water channel. Evidence for distinct transcriptional units

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Novel variants in human Aquaporin-4 reduce cellular water permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Heterotetrameric composition of aquaporin-4 water channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Live-cell imaging of aquaporin-4 diffusion and interactions in orthogonal arrays of particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Regulation of AQP4 protein expression in rat brain astrocytes: role of P2X7 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Synaptic P2X7 and oxygen/glucose deprivation in organotypic hippocampal cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Innate and adaptive autoimmunity directed to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Remyelination protects axons from demyelination-associated axon degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

NMO-IgG in the diagnosis of neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Greatly attenuated experimental autoimmune encephalomyelitis in aquaporin-4 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Neuromyelitis optica: diagnosis, pathogenesis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

A review of the current use of rituximab in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Characterisation of the spectrum of demyelinating disease in Western Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Characteristics of Devic's disease (neuromyelitis optica) in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

The spectrum of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01416.X

10.1111/J.1600-0404.2010.01416.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20880299%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference